About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Journal of Cardiovascular Pharmacology and Therapeutics
›
Top Articles
Journal of Cardiovascular Pharmacology and Therapeutics
Cardiology
,
Pharmacology
2.6
(top 7%)
Impact Factor
2.8
(top 7%)
extended IF
53
(top 8%)
H-Index
784
authors
1.3K
papers
18.7K
citations
2.9K
citing journals
13.9K
citing authors
Most Cited Articles of Journal of Cardiovascular Pharmacology and Therapeutics
Title
Year
Citations
Characterization of the adenosine pharmacology of ticagrelor reveals therapeutically relevant inhibition of equilibrative nucleoside transporter 1
2014
179
Ticagrelor inhibits adenosine uptake in vitro and enhances adenosine-mediated hyperemia responses in a canine model
2012
148
Metabolic Syndrome
2017
147
Arterial elastance and wave reflection augmentation of systolic blood pressure: deleterious effects and implications for therapy
2001
136
Inflammation and atherosclerosis--revisited
2014
133
Platelet P2Y₁₂ blockers confer direct postconditioning-like protection in reperfused rabbit hearts
2013
115
Cell death pathways in acute ischemia/reperfusion injury
2011
112
Electrophysiologic properties and antiarrhythmic actions of a novel antianginal agent
2004
104
Remote ischemic preconditioning: current knowledge, unresolved questions, and future priorities
2011
101
Adenosine receptor-mediated cardioprotection: are all 4 subtypes required or redundant?
2012
95
No-reflow phenomenon: maintaining vascular integrity
2011
94
Diuretics: a review and update
2014
93
Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarction
2005
92
Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease in Men with Hypogonadism: A Real-Life Observational Registry Study Setting Comparing Treated and Untreated (Control) Groups
2017
89
Losartan decreases cardiac muscle fibrosis and improves cardiac function in dystrophin-deficient mdx mice
2011
84
Physiologic properties and regulation of the actin cytoskeleton in vascular smooth muscle
2008
84
Pharmacotherapy update on the use of vasopressors and inotropes in the intensive care unit
2015
82
Autophagy: definition, molecular machinery, and potential role in myocardial ischemia-reperfusion injury
2010
82
Evaluation of methods for the measurement of low-density lipoprotein cholesterol
2005
80
Effect of Probiotic Lactobacillus salivarius UBL S22 and Prebiotic Fructo-oligosaccharide on Serum Lipids, Inflammatory Markers, Insulin Sensitivity, and Gut Bacteria in Healthy Young Volunteers: A Randomized Controlled Single-Blind Pilot Study
2015
78
Currying the heart: curcumin and cardioprotection
2009
78
Reduction of early reperfusion injury with the mitochondria-targeting peptide bendavia
2014
74
Perconditioning and postconditioning: current knowledge, knowledge gaps, barriers to adoption, and future directions
2011
73
Intravenous nitroglycerin in the treatment of decompensated heart failure: potential benefits and limitations
2004
68
How and when do myocytes die during ischemia and reperfusion: the late phase
2011
67
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.